Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07558655 · ClinicalTrials.gov registry record
The Glean Registry
A clinical trial, sponsored by Bright Uro.
- Active
- Registry status
- 500
- Enrollment target
NCT07558655: Active study, sponsored by Bright Uro.
NCT07558655 is a clinical trial that is active but no longer recruiting, run by Bright Uro. The registered enrollment target is 500 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07558655 is active but no longer recruiting, sponsored by Bright Uro.
- ACTIVE NOT RECRUITING
- Registry status
- 500 participants
- Enrollment target
Study Summary
A registry designed to collect real-world data (RWD) on the Glean Urodynamics System via a retrospective medical chart review.
Interventions
- DEVICE Glean Urodynamics System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2026-04-16 |
| Est. Completion | 2027-05 |
What the registry record for NCT07558655 still lists
NCT07558655 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Glean Urodynamics System is the first listed.
NCT07558655 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07558655 about?
NCT07558655 is a clinical study titled "The Glean Registry". A registry designed to collect real-world data (RWD) on the Glean Urodynamics System via a retrospective medical chart review.
What is the current status of trial NCT07558655?
This trial is currently active not recruiting. The enrollment target is 500 participants. The study started on 2026-04-16. Estimated completion is 2027-05.
What interventions are being tested in trial NCT07558655?
The interventions under investigation include: Glean Urodynamics System (DEVICE).
Who is sponsoring clinical trial NCT07558655?
This trial is sponsored by Bright Uro, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI